Shaanxi Tize Biological Technology Co., Ltd
Shaanxi Tize Biological Technology Co., Ltd. is a Chinese company based in Xi'an that focuses on the extraction of active ingredients from various plants. The firm has experience in processing and supplying plant-based extracts for both domestic and international markets. According to available information, the company engages in the production and distribution of a diverse portfolio of plant extracts to meet customer needs across different regions.
From the disclosed product slate, the company highlights several key extracts, including matrine, Magnolia Bark P. E., Common Cnidium Fruit P. E., nicotine at 99% purity, and other plant-derived extracts. This range suggests a specialization in botanical ingredients used for applications in health, nutrition, pharmaceuticals, or related industries. While specific applications or end-markets are not detailed, the emphasis on supplying products to home and aboard indicates a capacity for multi-regional distribution.
As a biotechnology-oriented entity, the company’s operations appear centered on the collection, processing, and refinement of plant materials to isolate active compounds. The information available does not provide explicit details about manufacturing processes, certifications, or quality control frameworks. Consequently, potential customers or partners seeking to collaborate with Shaanxi Tize Biological Technology Co., Ltd. should seek direct confirmation of compliance standards, regulatory approvals, and logistical capabilities relevant to cross-border supply.
The profile reflects a focus on botanical ingredients rather than freight forwarding or logistics services. For stakeholders researching this entity, the data suggests a supplier role in the supply chain for plant-based extracts, with an emphasis on a select group of compounds and related products. Additional information would be required to assess manufacturing capacity, lead times, pricing, and international shipping arrangements.
